LLY - ELI LILLY & Co
869.58
-43.180 -4.966%
Share volume: 4,818,093
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$912.76
-43.18
-0.05%
Summary score
81%
Profitability
100%
Dept financing
33%
Liquidity
57%
Performance
80%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
15.71%
Return on assets
4.24%
Return on sales
28.08%
Return on invested capital
9.78%
Total debt ratio
81.31%
Debt ratio change over timeo
-15.58%
Current Ratio
1.17%
Quick Ratio
0.91%
Cash Position Ratio
0.17%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
17.51%
Return on assets
4.29%
Return on sales
28.55%
Return on invested capital
11.13%
Total debt ratio
80.84%
Debt ratio change over timeo
4.11%
Current Ratio
1.25%
Quick Ratio
0.96%
Cash Position Ratio
0.13%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
6.4%
Return on sales
38.05%
Return on invested capital
0%
Total debt ratio
81.97%
Debt ratio change over time
0%
Current Ratio
1.15%
Quick Ratio
0.89%
Cash Position Ratio
0.12%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
69.67%
Return on assets
-196.56%
Return on sales
-687.42%
Return on invested capital
3.41%
Total debt ratio
-1557.58%
Debt ratio change over time
-15.58%
Current Ratio
-16.89%
Quick Ratio
-13.5%
Cash Position Ratio
-2.22%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LLY | NVO | NONOF | JNJ |
|---|---|---|---|---|
| Return on equity | 15.71% | 0% | 0% | 8.16% |
| Return on assets | 4.24% | 0% | 0% | 2.99% |
| Return on sales | 28.08% | 0% | 0% | 25.12% |
| Return on invested capital | 9.78% | 0% | 0% | 8.17% |
| Profitability | 100% | 0% | 0% | 74% |
| Total debt ratio | 81.31% | 0% | 0% | 59.66% |
| Debt ratio change over time | -15.58% | 0% | 0% | -27.85% |
| Dept financing | 25% | 0% | 25% | 18% |
| Current Ratio | 1.25% | 0% | 0% | 1.1% |
| Quick Ratio | 0.96% | 0% | 0% | 0.87% |
| Cash Position Ratio | 0.13% | 0% | 0% | 0.48% |
| Liquididy | 56% | 0% | 0% | 75% |
| Short-term ratios | LLY | NVO | NONOF | JNJ |
|---|---|---|---|---|
| Return on equity | 17.51% | 0% | 0% | 5.6% |
| Return on assets | 4.29% | 0% | 0% | 2.69% |
| Return on sales | 28.55% | 0% | 0% | 25.18% |
| Return on invested capital | 11.13% | 0% | 0% | 5.84% |
| Profitability | 100% | 0% | 0% | 59% |
| Total debt ratio | 80.84% | 0% | 0% | 60.09% |
| Debt ratio change over time | 4.11% | 0% | 0% | 9.02% |
| Dept financing | 36% | 0% | 0% | 44% |
| Current Ratio | 1.25% | 0% | 0% | 1.1% |
| Quick Ratio | 0.96% | 0% | 0% | 0.87% |
| Cash Position Ratio | 0.13% | 0% | 0% | 0.48% |
| Liquididy | 57% | 0% | 0% | 70% |